Literature DB >> 11883860

The puzzle of hormone replacement therapy (HRT) and cardiovascular disease (CVD).

Antonio Lanzone.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11883860     DOI： 10.1007/BF03343953

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  11 in total

Review 1.  Cardioprotective effects of ovarian hormones and the HERS in perspective.

Authors:  G M Rosano; A Graziottin; M Fini
Journal:  Maturitas       Date:  2000-04-01       Impact factor: 4.342

Review 2.  Clinical practice. Postmenopausal hormone-replacement therapy.

Authors:  J E Manson; K A Martin
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

3.  Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

Authors:  L Mosca; P Collins; D M Herrington; M E Mendelsohn; R C Pasternak; R M Robertson; K Schenck-Gustafsson; S C Smith ; K A Taubert; N K Wenger
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

4.  Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials.

Authors:  E Hemminki; K McPherson
Journal:  BMJ       Date:  1997-07-19

5.  Hormone replacement therapy, heart disease, and other considerations.

Authors:  E Barrett-Connor; D Grady
Journal:  Annu Rev Public Health       Date:  1998       Impact factor: 21.981

6.  Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.

Authors:  D M Herrington; D M Reboussin; K B Brosnihan; P C Sharp; S A Shumaker; T E Snyder; C D Furberg; G J Kowalchuk; T D Stuckey; W J Rogers; D H Givens; D Waters
Journal:  N Engl J Med       Date:  2000-08-24       Impact factor: 91.245

7.  Postmenopausal estrogen and progestin use and the risk of cardiovascular disease.

Authors:  F Grodstein; M J Stampfer; J E Manson; G A Colditz; W C Willett; B Rosner; F E Speizer; C H Hennekens
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

8.  Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study.

Authors:  C Varas-Lorenzo; L A García-Rodríguez; S Perez-Gutthann; A Duque-Oliart
Journal:  Circulation       Date:  2000-06-06       Impact factor: 29.690

9.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

10.  Decreased mortality in users of estrogen replacement therapy.

Authors:  B E Henderson; A Paganini-Hill; R K Ross
Journal:  Arch Intern Med       Date:  1991-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.